You are here

  • Home
  • Online First
  • Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)

Article info

Article menu

other Versions

Download PDFPDF
Clinical trial
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)

Authors

  • Gabriella Macchia Radiotherapy Unit, Gemelli Molise Hospital, Campobasso, Italy PubMed articlesGoogle scholar articles
  • Barbara Alicja Jereczek-Fossa Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milano, ItalyDepartment of Oncology and Hemato-oncology, University of Milan, Milano, Italy PubMed articlesGoogle scholar articles
  • Roberta Lazzari Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milano, Italy PubMed articlesGoogle scholar articles
  • Annamaria Cerrotta Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy PubMed articlesGoogle scholar articles
  • Francesco Deodato Radiotherapy Unit, Gemelli Molise Hospital, Campobasso, ItalyIstituto di Radiologia, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy PubMed articlesGoogle scholar articles
  • Edy Ippolito Department of Radiation Oncology, Campus Bio-Medico University, Roma, Italy PubMed articlesGoogle scholar articles
  • Cynthia Aristei Radiation Oncology Section, University of Perugia and Perugia General Hospital, Perugia, Italy PubMed articlesGoogle scholar articles
  • Maria Antonietta Gambacorta Istituto di Radiologia, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, ItalyUnità Operativa Complessa di Radioterapia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy PubMed articlesGoogle scholar articles
  • Giovanni Scambia Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, ItalyIstituto di Ginecologia e Ostetricia, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy PubMed articlesGoogle scholar articles
  • Vincenzo Valentini Istituto di Radiologia, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, ItalyUnità Operativa Complessa di Radioterapia, Dipartimento di Scienze Radiologiche, Radioterapiche ed Ematologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy PubMed articlesGoogle scholar articles
  • Gabriella Ferrandina Gynecologic Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, ItalyIstituto di Ginecologia e Ostetricia, Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia, Roma, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Gabriella Macchia, Radiotherapy Unit, Gemelli Molise, Campobasso, Molise, Italy; macchiagabriella{at}gmail.com
View Full Text

Citation

Macchia G, Jereczek-Fossa BA, Lazzari R, et al
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD)
International Journal of Gynecologic Cancer Published Online First: 21 June 2021. doi: 10.1136/ijgc-2021-002709

Publication history

  • Accepted June 4, 2021
  • First published June 21, 2021.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.